Latest Funding News

Resolute Mining’s scoping study for its ABC Project in Côte d’Ivoire outlines a robust 12-year open pit gold operation with strong economic metrics, including a post-tax NPV of US$1.2 billion and a 39% IRR at US$3,500/oz gold.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

Healius updates FY26 guidance with modest earnings growth, flags wage cost pressures from Fair Work ruling, and initiates sale process for high-growth Agilex Biolabs.

Arafura Rare Earths has secured a binding offtake term sheet with Traxys North America to supply 500 tonnes per annum of NdPr oxide, underpinning its Nolans Project and supporting US critical minerals supply chains.

Genmin has drawn strong international interest to finance its Baniaka iron ore project in Gabon, with proposals ranging from joint ventures to prepayment facilities. The Gabonese government backs the project as a national priority, aiming for a final investment decision by mid-2026.

Commonwealth Bank of Australia reported a steady cash profit of around $2.7 billion in 3Q26, balancing disciplined lending growth and cautious provisioning amid geopolitical and economic uncertainties.

Marlin Global delivered a 4.0% gross portfolio return in April 2026, driven by strong gains in AI-focused tech stocks like Amazon and Alphabet. However, its cautious stance on semiconductors limited upside amid a sector rally.

Barramundi Limited outperformed the S&P/ASX200 in April with a 4.4% gross return, boosted by NEXT DC’s landmark data centre deal and capital raise, while healthcare stocks faced headwinds from Cochlear’s profit downgrade.

Kingfish Limited’s portfolio edged higher in April, buoyed by strong performances from Mercury and Infratil, while a2 Milk and Summerset weighed on returns amid operational and economic headwinds.

Pacific Edge has raised NZ$25.4 million through an oversubscribed placement priced at NZ$0.17 per share, aiming to bolster operations, support Medicare re-coverage efforts, and advance its bladder cancer diagnostic tests.

Radius Residential Care delivered a standout FY26 with profit before tax surging 37% to $14.3 million, a 50% hike in its final dividend, and growth fueled by acquisitions and new developments.

Tartana Minerals revises its corporate presentation to clarify prior disclosures while spotlighting a $4.5 million capital raise to boost copper sulphate production and expand drilling across its Far North Queensland portfolio.